Antioxidant response element Regulation of gene expression Free radicals Nrf2:INrf2 (Keap1) are cellular sensors of chemical-and radiation-induced oxidative and electrophilic stress. Nrf2 is a nuclear transcription factor that controls the expression and coordinated induction of a battery of defensive genes encoding detoxifying enzymes and antioxidant proteins. This is a mechanism of critical importance for cellular protection and cell survival. Nrf2 is retained in the cytoplasm by an inhibitor, INrf2 which functions as an adapter for Cul3/Rbx1-mediated degradation of Nrf2. In response to oxidative/ electrophilic stress, Nrf2 is switched on and then off by distinct early and delayed mechanisms. Oxidative/ electrophilic modification of INrf2 cysteine 151 and/or protein kinase C phosphorylation of Nrf2 serine 40 results in the escape or release of Nrf2 from INrf2. Nrf2 is stabilized and translocates to the nucleus, forms heterodimers with unknown proteins, and binds the antioxidant response element, which leads to coordinated activation of gene expression. It takes less than 15 min from the time of exposure to switch on nuclear import of Nrf2. This is followed by activation of a delayed mechanism that controls the switching off of Nrf2 activation of gene expression. GSK3β phosphorylates Fyn at an unknown threonine residue(s), leading to the nuclear localization of Fyn. Fyn phosphorylates Nrf2 tyrosine 568, resulting in the nuclear export of Nrf2, binding with INrf2, and degradation of Nrf2. The switching on and off of Nrf2 protects cells against free radical damage, prevents apoptosis, and promotes cell survival.
Introduction
Oxidative stress is induced by a vast range of factors including xenobiotics, drugs, heavy metals, and ionizing radiation. Oxidative stress leads to the generation of reactive oxygen species (ROS) and electrophiles. ROS and electrophiles that are generated can have a profound impact on survival, growth development, and evolution of all living organisms [1, 2] . ROS include both free radicals, such as the superoxide anion and the hydroxyl radical, and oxidants such as hydrogen peroxide [3] . ROS and electrophiles can cause diseases such as cancer, cardiovascular complications, acute and chronic inflammation, and neurodegenerative diseases [1] . Therefore, it is obvious that cells must constantly labor to control the levels of ROS, preventing them from accumulating.
Much of what we know about the mechanisms of protection against oxidative stress has come from the study of prokaryotic cells [4, 5] . Prokaryotic cells utilize the transcription factors OxyR and SoxRS to sense the redox state of the cell, and during oxidative stress these factors induce the expression of nearly 80 defensive genes [5] . Eukaryotic cells have similar mechanisms to protect against oxidative stress ( Fig. 1) [3, [6] [7] [8] [9] . The initial effects of oxidative/electrophilic stress lead to the activation of the expression of a battery of defensive genes, which leads to detoxification of chemicals and ROS and the prevention of free radical generation and cell survival (Fig. 1) . Of these genes, some are enzymes such as NAD(P)H:quinine oxidoreductase 1 (NQO1), NRH:quinone oxidoreductase 2, glutathione S-transferase Ya (GST Ya) subunit, heme oxygenase 1 (HO-1), and γ-glutamylcysteine synthetase (γ-GCS), also known as glutamate cysteine ligase. Other genes have end products that regulate a wide variety of cellular activities including signal transduction, proliferation, and immunological defense reactions. There is a wide variety of factors associated with the cellular response to oxidative stress. For example, NF-E2-related factor 2 (Nrf2), heat-shock-response activator protein 1, and NF-κB promote cell survival, whereas activation of c-jun, N-terminal kinases, p38 kinase, and TP53 may lead to cell cycle arrest and apoptosis [10] . The Nrf2 pathway is regarded as the most important in the cell to protect against oxidative stress [3, [6] [7] [8] [9] . It is noteworthy that accumulation of ROS and/or electrophiles leads to oxidative/ electrophile stress, membrane damage, DNA adduct formation, and mutagenicity ( Fig. 1) . These changes lead to degeneration of tissues and premature aging, apoptotic cell death, cellular transformation, and cancer.
Antioxidant-response element and Nrf2
Promoter analysis identified a cis-acting enhancer sequence designated as the antioxidant-response element (ARE), which controls the basal and inducible expression of antioxidant genes in response to xenobiotics, antioxidants, heavy metals, and UV light [11] . The ARE sequence is responsive to a broad range of structurally diverse chemicals apart from β-naphthoflavone and phenolic antioxidants [12] . Mutational analysis revealed GTGACA⁎⁎⁎GC to be the core sequence of the ARE [11, 13, 14] . This core sequence is present in all Nrf2 downstream genes that respond to antioxidants and xenobiotics [3, [6] [7] [8] [9] . Nrf2 binds to the ARE and regulates AREmediated antioxidant enzyme gene expression and induction in response to a variety of stimuli, including antioxidants, xenobiotics, metals, and UV irradiation [6, [15] [16] [17] [18] [19] [20] [21] .
Nrf2 is ubiquitously expressed in a wide range of tissue and cell types [22] [23] [24] and belongs to a subset of basic leucine zipper genes (bZIP) sharing a conserved structural domain that is designated as a cap'n'collar domain and is highly conserved in Drosophila transcription factor CNC (Fig. 2) [25] . The basic region, just upstream of the leucine zipper region, is responsible for DNA binding [3] , and the acidic region is required for transcriptional activation. ARE-mediated transcriptional activation requires heterodimerization of Nrf2 with other bZIP proteins, including Jun (c-Jun, Jun-D, and Jun-B) and small Maf (MafG, MafK, MafF) proteins [18] [19] [20] [26] [27] .
Initial evidence demonstrating the role of Nrf2 in antioxidant induction of detoxifying enzymes came from studies on the role of Nrf2 in ARE-mediated regulation of NQO1 gene expression [17] . Nrf2 was subsequently shown to be involved in the transcriptional activation of other ARE-responsive genes such as GST Ya, γ-GCS, HO-1, antioxidants, proteasomes, and drug transporters [3, [6] [7] [8] [9] [28] [29] [30] [31] [32] [33] . Overexpression of Nrf2, by Nrf2-cDNA, was shown to upregulate the expression and induction of the NQO1 gene in response to antioxidants and xenobiotics [17] . In addition, Nrf2-null mice exhibited a marked decrease in the expression and induction of NQO1, indicating that Nrf2 plays an essential role in the in vivo regulation of NQO1 in response to oxidative stress [26] . The importance of this transcription factor in upregulating ARE-mediated gene expression has been demonstrated by several in vivo and in vitro studies [reviewed in 3]. The results indicate that Nrf2 is an important activator of phase II antioxidant genes [3, 8] .
Negative regulation of Nrf2 mediated by INrf2
A cytosolic inhibitor (INrf2), also known as Keap1 (Kelch-like ECHassociating protein 1), of Nrf2 was identified and reported ( Fig. 2 ) [34, 35] . INrf2, existing as a dimer [36] , retains Nrf2 in the cytoplasm. Analysis of the INrf2 amino acid sequence and domain structurefunction analyses have revealed that INrf2 has a BTB (broad complex, tramtrack, bric-a-brac)/POZ (poxvirus, zinc finger) domain and a Kelch domain [34, 35] , also known as the double-glycine repeat domain [37] . Keap1 has three additional domains/regions: the Nterminal region, the intervening region, and the C-terminal region [8] . The BTB/POZ domain has been shown to be a protein-protein interaction domain. In Drosophila INrf2 kelch domain and intracisternal a particle promoted polypeptide (IPP) kelch domain binds to actin [38, 39] , allowing the scaffolding of INrf2 to the actin cytoskeleton, which plays an important role in Nrf2 retention in the cytosol [40] . The main function of INrf2 is to serve as an adapter for the cullin 3/ring box 1 (Cul3/Rbx1) E3 ubiquitin ligase complex [41] [42] [43] . Cul3 serves as a scaffold protein that forms the E3 ligase complex with Rbx1 and recruits a cognate E2 enzyme [8] . INrf2, via its N-terminal BTB/POZ domain, binds to Cul3 [44] and, via its C-terminal Kelch domain, binds to the substrate Nrf2, leading to the ubiquitination and degradation of Nrf2 through the 26S proteasome [45] [46] [47] [48] [49] . Under normal cellular conditions, the cytosolic INrf2/Cul3/Rbx1 complex is constantly degrading Nrf2. When a cell is exposed to oxidative stress Nrf2 dissociates from the INrf2 complex, stabilizes, and translocates into the nucleus, leading to activation of ARE-mediated gene expression [3, [6] [7] [8] [9] . An alternative theory is that Nrf2 in response to oxidative stress escapes INrf2 degradation, stabilizes, and translocates into the nucleus [49, 50] . We suggested the theory of escape of Nrf2 from INrf2 [49] and a similar suggestion was also made in another report [50] . However, the follow-up studies in our laboratory could not support the escape theory. Escape theory is a possibility but has to be proven by experiments before it can be adapted. Therefore, we will use the release of Nrf2 from INrf2 in the rest of this review.
Numerous reports have suggested that any mechanism that modifies INrf2 and/or Nrf2 disrupting the Nrf2:INrf2 interaction will result in the upregulation of ARE-mediated gene expression. A model of Nrf2:INrf2 signaling from antioxidant and xenobiotic to activation of ARE-mediated defensive gene expression is shown in Fig. 3 . Because the metabolism of antioxidants and xenobiotics results in the generation of ROS and electrophiles [51] , it is thought that these molecules might act as second messengers, activating ARE-mediated gene expression. Several protein kinases, including PKC, ERK, MAPK, p38, and PERK [49, [52] [53] [54] [55] [56] , are known to modify Nrf2 and activate its release from INrf2. Among these mechanisms, oxidative/electrophilic stress-mediated phosphorylation of Nrf2 at serine 40 by PKC is necessary for Nrf2 release from INrf2, but is not required for Nrf2 accumulation in the nucleus [49, 52, 53] . In addition to posttranslational modification in Nrf2, several crucial residues in INrf2 have also been proposed to be important for activation of Nrf2. Studies based on electrophile-mediated modification, location, and mutational analyses revealed that three cysteine residues, Cys151, Cys273, and Cys288, are crucial for INrf2 activity [50] . INrf2 itself undergoes ubiquitination by the Cul3 complex, via a proteasomal independent pathway, which was markedly increased in response to phase II inducers such as antioxidants [57] . It has been suggested that normally INrf2 targets Nrf2 for ubiquitin-mediated degradation but electrophiles may trigger a switch of Cul3-dependent ubiquitination from Nrf2 to INrf2, resulting in ARE gene induction. The redox modulation of cysteines in INrf2 might be a mechanism redundant to the phosphorylation of Nrf2 by PKC, or the two mechanisms may work in concert. In addition to cysteine 151 modification, phosphorylation of Nrf2 has been shown to play a role in INrf2 retention and the release of Nrf2. Serine 104 of INrf2 is required for dimerization of INrf2, and mutations of serine 104 led to the disruption of the INrf2 dimer and the release of Nrf2 [36] . Recently, Eggler at al. demonstrated that modifying specific cysteines of the electrophile-sensing human INrf2 protein is insufficient to disrupt binding to the Nrf2 domain Neh2 [58] . Upon introduction of electrophiles, modification of INrf2C151 leads to a change in the conformation of the BTB domain by means of perturbing the homodimerization site, disrupting Neh2 ubiquitination and causing ubiquitination of INrf2. Modification of INrf2 cysteines by electrophiles does not lead to disruption of the INrf2/Nrf2 complex. Rather, the switch of ubiquitination from Nrf2 to INrf2 leads to Nrf2 nuclear accumulation. More recently, our laboratory demonstrated that phosphorylation and dephosphorylation of tyrosine 141 in INrf2 regulate its stability and degradation, respectively [59] . The dephosphorylation of tyrosine 141 caused destabilization and degradation of INrf2, leading to the release of Nrf2. Furthermore, we showed that prothymosin-α mediates nuclear import of the INrf2/Cul3/Rbx1 complex [60] . The INrf2/Cul3/Rbx1 complex inside the nucleus exchanges prothymosin-α with Nrf2, resulting in degradation of Nrf2. These results led to the conclusion that prothymosin-α-mediated nuclear import of INrf2/Cul3/Rbx1 complex leads to the ubiquitination and degradation of nuclear Nrf2, presumably to regulate the nuclear level of Nrf2 and rapidly switch off the activation of Nrf2 downstream gene expression. An autoregulatory loop also exists within the Nrf2 pathway [61] .
Other regulatory mediators of Nrf2
Bach1 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) is a transcription repressor [62] that is ubiquitously expressed in tissues [63, 64] and distantly related to Nrf2 [8] . In the absence of cellular stress, Bach1 heterodimerizes with small Maf proteins [65] that bind to the ARE [66] , repressing gene expression. In the presence of oxidative stress, Bach1 releases from the ARE and is replaced by Nrf2. Bach1 competes with Nrf2 for binding to the ARE, leading to suppression of Nrf2 downstream genes [66] .
Nuclear import of Nrf2, from the time of exposure to stabilization, takes roughly 2 h [67] . This is followed by activation of a delayed mechanism involving glycogen synthase kinase 3β (GSK3β), which controls the switching off of Nrf2 activation of gene expression (Fig.  3 ). GSK3β is a multifunctional serine/threonine kinase and plays a major role in various signaling pathways [68] . GSK3β phosphorylates Fyn, a tyrosine kinase, at an unknown threonine residue(s), leading to the nuclear localization of Fyn [69] . Fyn phosphorylates Nrf2 tyrosine 568, resulting in nuclear export of Nrf2, binding with INrf2, and degradation of Nrf2 [70] .
The negative regulation of Nrf2 by Bach1 and GSK3β/Fyn are important in repressing Nrf2 downstream genes that were induced in response to oxidative/electrophilic stress. The tight control of Nrf2 is vital for the cell's protection against free radical damage, prevention of apoptosis, and survival [3, [6] [7] [8] [9] 70] .
Nrf2 in cytoprotection, cancer, and drug resistance
Nrf2 plays a major role in the protective mechanism against xenobiotics capable of damaging DNA and initiating carcinogenesis [71] . Inducers of Nrf2 function as blocking agents that prevent carcinogens from reaching target sites, inhibit parent molecules from undergoing metabolic activation, or subsequently prevent carcinogenic species from interacting with crucial cellular macromolecules, such as DNA, RNA, and proteins [72] . A plausible mechanism by which blocking agents impart their chemopreventive activity is the induction of detoxification and antioxidant enzymes [73] . Oltipraz, 3H-1,2,-dithiole-3-thione, sulforaphane, and curcumin can be considered potential chemopreventive agents because these compounds have all been shown to induce Nrf2 [74] [75] [76] [77] [78] [79] [80] [81] .
Studies have shown a role for Nrf2 in protection against cadmium and manganese toxicity [82] . Nrf2 also plays an important role in the reduction of methylmercury toxicity [83] . Methylmercury activates Nrf2, and the activation of Nrf2 is essential for reduction of methylmercury by facilitating its excretion into extracellular space. In vitro and in vivo studies have shown a role for Nrf2 in neuroprotection and protection against Parkinson disease [84] [85] [86] . Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice [87] . Nrf2-knockout mice were more prone to tumor growth when exposed to carcinogens such as benzo[a]pyrene, diesel exhaust, and N-nitrosobutyl(4-hydroxybutyl) amine [88] [89] [90] . INrf2/Nrf2 signaling has also been shown to regulate oxidative stress tolerance and life span in Drosophila [91] .
A role for Nrf2 in drug resistance is suggested based on its property to induce detoxifying and antioxidant enzymes [92] [93] [94] [95] [96] [97] . The loss of INrf2 (Keap1) function has been shown to lead to nuclear accumulation of Nrf2, activation of metabolizing enzymes, and drug resistance [95] . Studies have reported mutations resulting in dysfunctional INrf2 in lung, breast, and bladder cancers [96] [97] [98] [99] [100] . A recent study reported that somatic mutations also occur in the coding region of Nrf2, especially in cancer patients with a history of smoking or suffering from squamous cell carcinoma [101] . These mutations abrogate its interaction with INrf2 and nuclear accumulation of Nrf2. This gives an advantage to cancer cell survival and undue protection from anti-cancer treatments. However, the understanding of the mechanism of Nrf2-induced drug resistance remains in its infancy. In addition, the studies on Nrf2-regulated downstream pathways that contribute to drug resistance remain limited.
Future perspectives
Nrf2 creates a new paradigm in cytoprotection, cancer prevention, and drug resistance. Considerable progress has been made to better understand all the mechanisms involved in the intracellular pathways regulating Nrf2 and its downstream genes. Preliminary studies demonstrate that deactivation of Nrf2 is as important as activation of Nrf2. Further studies are needed to better understand the negative regulation of Nrf2. Also, a better understanding of the negative regulation of Nrf2 could help in the design of a new class of effective chemopreventive compounds targeting not only Nrf2 activation, but also the negative regulators of Nrf2.
